Background/Aims: In order to define a label sun protection factor (SPF) of topically applied sunscreens, in vivo test methods like ISO 24444, FDA guideline, or the Australian standard are used worldwide. The basis of all these methods is provoking an erythemal skin reaction by UV irradiation to find the level of unprotected and protected minimal erythemal doses (MED). In vitro methods replacing the human skin by any kind of non-human material are still not available. Thus, offering the new hybrid diffuse reflectance spectroscopy (HDRS) technique that is able to stay on an in vivo level for SPF testing but meanwhile neglecting the UV-dose-related erythemal skin reaction is a perfect combination to take care of sun protection and any ethical concerns in SPF testing nowadays. Methods: HDRS is a combination of in vivo diffuse reflectance spectroscopy (DRS) measurements on the skin and in vitro transmission measurements of a sunscreen on a roughened polymethylmethacrylate plate. By this technique, the in vivo behavior of the investigated sunscreen on the skin is measured as well as the UVB absorption, which is still non-visible in the reflectance technique. In order to establish an alternative method for in vivo SPF testing, a huge number of sunscreens (80 samples) was measured by HDRS and compared to the worldwide accepted standard ISO 24444. The variety of sunscreens measured reflects a wide range of different types of formulations as well as a wide range of SPFs (5–120) to validate this new alternative SPF testing procedure. Results: The applied quantity of product as well as skin color dependencies of signal generation are shown to support any basic correlation of DRS signal generation and sun protection expectations. Far-reaching statistical data analyses show an excellent link of the new non-erythemally driven HDRS-SPF technique and ISO 24444 results. In the same way, HDRS-UVA-PF results can be correlated with UVA-PF values calculated from ISO 24443. Conclusion: Due to the elimination of any erythemal relevant UVB and UVA doses, absolutely no skin reaction occurs. Consequently there is no need to define a MED any more. For the first time an alternative way to SPF is shown without any ethical concerns of SPF testing in vivo and/or any restriction of SPF testing in vitro. Regardless of the type of formulation or the level of protection, an excellent correlation of SPFHDRS and SPF24444 for sunscreen labeling could be found. By this new alternative non-erythemal technique, not only SPF values can be measured, but also UVA-PF values can be calculated with an excellent correlation to ISO 24443 from the same set of data. For the first time a robust alternative test method of SPF- and UVA-PF values is described, taking into account the interaction of sunscreen formulation and skin.

Keywords:
Diffuse reflectance spectroscopy, Hybrid diffuse reflectance spectroscopy, Sun protection factor, in vivo, Non-erythemal testing
1.
ISO 24444: 2010, cosmetics – sun protection test methods: in vivo determination of the sun protection factor (SPF). International Organization for Standardization, 2010.
2.
Food and Drug Administration: Labeling and effectiveness testing: sunscreen drug products for over-the-counter human use, 21 CFR parts 201 and 310, June 2011.
3.
Australian/New Zealand StandardTM: sunscreen products – evaluation and classification. AS/NZS 2604: 2012.
4.
Diffey BL, Robson J: A new substrate to measure sunscreen protection factor throughout the ultraviolet spectrum. J Soc Cosmet Chem 1989; 40: 127–133.
5.
Cole CA, Van Fossen RL: In vitro models for UVB and UVA photoprotection; in Lowe NJ, Shaath NA (eds): Sunscreens Development, Evaluation, and Regulatory Aspects. New York, Dekker, 1990, pp 395–404.
6.
Herzog B: Prediction of sun protection factors by calculation of transmissions with a calibrated step film model. J Cosmet Sci 2002; 53: 11–26.
7.
Stanfield JW: In vitro techniques in sunscreen development; in Shaath N (ed): Sunscreens: Regulations and Commercial Development, ed 3. Boca Raton, Taylor & Francis, 2005, vol 205, pp 843–879.
8.
Pissavini M, Ferrero L, Alard V, et al: Determination of the in vitro SPF. Cosmet Toiletries 2003; 118: 10–63.
9.
Stanfield JW, Osterwalder U, Herzog B: In vitro measurements of sunscreen protection. Photochem Photobiol Sci 2010; 9: 489–494.
10.
Rohr M, Klette E, Ruppert S, et al: In vitro sun protection factor: still a challenge with no final answer. Skin Pharmacol Physiol 2010; 23: 201–212.
11.
Rohr M, Klette E, Kockott D, et al: In vivo and in vitro SPF determination – two sides of the same coin? IFSCC Mag 2012; 2: 97–103.
12.
Sohn M, Malburet C, Baptiste L, Prigl Y: Development of a synthetic substrate for the in vitro performance testing of sunscreens. Skin Pharmacol Physiol 2017; 30: 159–170.
13.
Zastrow L, Groth N, Klein F, et al: The missing link – light-induced (280–1,600 nm) free radical formation in human skin. Skin Pharmacol Physiol 2009; 22: 31–44.
14.
Souza C, Maia Campos P, Schanzer S, et al: Radical-scavenging activity of a sunscreen enriched by antioxidants providing protection in the whole solar spectral range. Skin Pharmacol Physiol 2017; 30: 81–89.
15.
Schroeder P, Krutmann J: What is needed for a sunscreen to provide complete protection. Skin Ther Lett 2010; 15: 4–5.
16.
Sohn M, Heche A, Herzog B, Imanidis G: Film thickness frequency distribution of different vehicles determines sunscreen efficacy. J Biomed Opt 2014; 19: 115005-1–115005-11.
17.
Ferrero L, Pissavini M, Douceta O: How a calculated model of sunscreen film geometry can explain in vitro and in vivo SPF variation. Photochem Photobiol Sci 2010; 9: 540–551.
18.
Fujikake K, Tago S, Plasson R, et al: Problems of in vitro SPF measurements brought about by viscous fingering generated during sunscreen applications. Skin Pharmacol Physiol 2014; 27: 254–262.
19.
Acker S, Hloucha M, Osterwalder U: The easy way to make a sunscreen. SOFW 2014; 140: 24–30.
20.
Osterwalder U, Janssen A, Schlifke A: New tool simplifies the development of sunscreens. COSSMA 2018; 1–2: 20–24.
21.
ISO/24443, cosmetics – sun protection test methods: determination of sunscreen UVA photoprotection in vitro. International Organization for Standardization, 2011.
22.
Gillies R, Moyal D, Forestier S, Kollias N: Non-invasive in vivo determination of UVA efficacy of sunscreens using diffuse reflectance spectroscopy. Photodermatol Photoimmunol Photomed 2003; 19: 190–94.
23.
Gillies R, Kollias N: Noninvasive in vivo determination of sunscreen ultraviolet A protection factors using diffuse reflectance spectroscopy; in Lowe N, Shaath N, Pathak M (eds): Sunscreens: Development, Evaluation and Regulatory Aspects. New York, Dekker, 1997, pp 601–608.
24.
Moyal D, Refregier J, Chardon A: In vivo measurement of the photostability of sunscreen products using diffuse reflectance spectroscopy. Photodermatol Photoimmunol Photomed 2002; 18: 14–2.
25.
Ruvolo E Jr, Chu M, Grossman F, Cole C, Kollias N: Diffuse reflectance spectroscopy for ultraviolet A protection factor measurement: correlation studies between in vitro and in vivo measurements. Photodermatol Photoimmunol Photomed 2009; 25: 298–304.
26.
Ruvolo E Jr, Kollias N, Cole C: New noninvasive approach assessing in vivo sun protection factor (SPF) using diffuse reflectance spectroscopy (DRS) and in vitro transmission. Photodermatol Photoimmunol Photomed 2014; 30: 202–211.
27.
Parrish JA, Jaenicke KF, Anderson RR: Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol 1982; 36: 187–191.
28.
Chardon A, et al: Skin colour typology and suntanning pathways. Int J Cosmet Sci 1991; 13: 191–208.
29.
Rohr M, Schrader A, Schrader K: Determination of SPFs in accordance with the COLIPA TF SPM recommendations (1994) – a report on 5 years’ practical experience including the field of water resistance. Parfümerie Kosmet 1998; 5: 12–19.
30.
Bimczok R, Gers-Barlag H, Mundt C, et al: Influence of applied quantity of sunscreen products on the sun protection factor – a multicenter study organized by the DGK Task Force Sun Protection. Skin Pharmacol Physiol 2007; 20: 7–64.
31.
Nielsen KP, et al: Reflectance spectra of pigmented and nonpigmented skin in the UV spectral region. Photochem Photobiol Sci 2004; 80: 450–455.
32.
Li L, So-ling Ng C: A physically based human skin reflection model. Proceedings of the 10th WSEAS Conf Automation and Information, Prague, 2009, pp 25–30.
33.
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986;i: 307–316.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.